GLENMARK
SUPPLY CHAIN
MANAGEMENT
MARKET INFO
• GPL has three facilities dedicated for manufacturing
APIs. The plants situated in Ankleshwar, Gujarat and
Kurkumbh & Mohol in Maharashtra, together
manufacture over 100 APIs
• Glen mark operates in the following countries
• India
• Africa/Middle-East
• Russia /CIS
• Latin America
• Central and Eastern Europe
MANUFACTURING FACILITIES
• Nasik - India
• Baddi - India
• Nalagarh – India
• Vysoke Myto – Czech Republic
• Sao Paulo – Brazil
• Nairobi – Kenya
• Dar Es Salaam - Tanzania
SCM FLOW CHART
OVERVIEW OF SCM
• Glenmark India Has a total product range of 300
products of which 22 products are patented products
under the name Glenmark.
• GlenMark also Hosts additional 46 patented brands
exclusively for the International Markets including the
other generic drugs.
SCM
• For Procurement of Raw Materials at the existing
4 manufacturing locations across the globe,
Glenmark holds a strategy of (Lease) Acquisition
of smaller companies producing the raw
material.
• This raw material is generally segregated into
two categories :
A)GDPRM(Generic Drug Production Raw
Material)
B) MPRM(Molecule Production Raw Material)
SCM IN INDIA
List of Suppliers in India :
• Dr. Reddy’s
• Lupin
• Aurobindo Pharma
• SunPharma
• Associated Capsules/CapsuGel
LOGISTICS FLOW
DISTRIBUTION NETWORK
LOGISTICS AND DISTRIBUTION
STRATEGY
Criteria for Selection of Distributors across global
operations :
• Market Penetration/Coverage
• Financial Capability
• Infrastructure Capacity
• Tie-ups
• Volume of Business Handled
• Product Pro-efficiency
• Time Factor
• Non Compete Clause
• Customer Feedback
DISTRIBUTOR MOTIVATION
• Performance Linked Incentives
• Competitions
• Facilities/Product Knowledge
• Orientation
• Sponsorships
• Credit Systems
THANK YOU!

Glenmark

  • 1.
  • 2.
    MARKET INFO • GPLhas three facilities dedicated for manufacturing APIs. The plants situated in Ankleshwar, Gujarat and Kurkumbh & Mohol in Maharashtra, together manufacture over 100 APIs • Glen mark operates in the following countries • India • Africa/Middle-East • Russia /CIS • Latin America • Central and Eastern Europe
  • 3.
    MANUFACTURING FACILITIES • Nasik- India • Baddi - India • Nalagarh – India • Vysoke Myto – Czech Republic • Sao Paulo – Brazil • Nairobi – Kenya • Dar Es Salaam - Tanzania
  • 4.
  • 5.
    OVERVIEW OF SCM •Glenmark India Has a total product range of 300 products of which 22 products are patented products under the name Glenmark. • GlenMark also Hosts additional 46 patented brands exclusively for the International Markets including the other generic drugs.
  • 6.
    SCM • For Procurementof Raw Materials at the existing 4 manufacturing locations across the globe, Glenmark holds a strategy of (Lease) Acquisition of smaller companies producing the raw material. • This raw material is generally segregated into two categories : A)GDPRM(Generic Drug Production Raw Material) B) MPRM(Molecule Production Raw Material)
  • 7.
    SCM IN INDIA Listof Suppliers in India : • Dr. Reddy’s • Lupin • Aurobindo Pharma • SunPharma • Associated Capsules/CapsuGel
  • 8.
  • 9.
  • 10.
    LOGISTICS AND DISTRIBUTION STRATEGY Criteriafor Selection of Distributors across global operations : • Market Penetration/Coverage • Financial Capability • Infrastructure Capacity • Tie-ups • Volume of Business Handled • Product Pro-efficiency • Time Factor • Non Compete Clause • Customer Feedback
  • 11.
    DISTRIBUTOR MOTIVATION • PerformanceLinked Incentives • Competitions • Facilities/Product Knowledge • Orientation • Sponsorships • Credit Systems
  • 12.